Core Points - The company announced an adjustment to the conversion price of its convertible bonds based on the 2024 profit distribution plan, reducing the price from 16.09 CNY to 15.92 CNY per share [2][5] - The adjustment will take effect on August 20, 2025, following the company's cash dividend distribution of 1.70 CNY per 10 shares [3][5] Summary of Convertible Bonds - The company issued 85 million convertible bonds with a face value of 100 CNY each, raising a total of 850 million CNY, netting 847.875 million CNY after deducting issuance costs [2] - The initial conversion price was set at 16.09 CNY per share, with the conversion period starting six months after the issuance [2] Basis for Conversion Price Adjustment - The adjustment is based on the company's profit distribution plan approved at the third extraordinary general meeting on July 1, 2025, which includes a cash dividend of 1.70 CNY per 10 shares [3][4] - The adjusted conversion price formula is P1 = P0 - D, where D is the cash dividend per share [4] Results of Conversion Price Adjustment - The adjusted conversion price is calculated to be approximately 15.92 CNY per share, effective from the ex-dividend date of August 20, 2025 [5] - The cash dividend per share, after considering the total share capital, is approximately 0.1685 CNY [5][9] Profit Distribution Plan - The profit distribution plan for the fiscal year 2024 includes a cash dividend of 0.17 CNY per share, totaling approximately 2.017 billion CNY [7][9] - The distribution will be made to all shareholders registered by the close of trading on August 19, 2025 [8] Tax Implications - For individual shareholders, the cash dividend will not be subject to withholding tax at the time of distribution, with tax calculated based on the holding period upon sale of shares [13] - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.153 CNY per share [14]

Core Viewpoint - Sanxin Medical announced on August 13 that it is expanding its operational scale and increasing its demand for working capital due to the growth in the medical device industry [2] Group 1: Company Overview - Sanxin Medical has a strong foundation in the medical device industry, leading to continuous expansion of its operational scale [2] - The company plans to issue convertible bonds to enhance its financial strength and optimize its asset structure [2] Group 2: Financial Strategy - The company aims to raise no more than 530 million yuan through the issuance of convertible bonds, which will be used for various projects and to supplement working capital [2] - The funds will specifically support the expansion of production lines for blood dialysis membranes and devices, as well as the establishment of a new production line for blood dialysis tubing [2]

Core Viewpoint - Zhejiang Xinhua Chemical Co., Ltd. has successfully issued convertible bonds totaling RMB 65 million, with a net amount of RMB 63.93 million after deducting issuance costs, to be used for specific investment projects [2][11]. Group 1: Approval and Issuance Details - The issuance of convertible bonds was approved by the China Securities Regulatory Commission, allowing the company to issue 6.5 million bonds at a face value of RMB 100 each [2]. - The bonds were listed on the Shanghai Stock Exchange on December 16, 2022, under the name "Xinhua Convertible Bonds" with the code "113663" [2][14]. Group 2: Bond Terms - The bonds have a term of up to 6 years, from November 28, 2022, to November 27, 2028, with an annual interest rate that increases from 0.3% in the first year to 3.0% in the sixth year [2][14]. - The initial conversion price is set at RMB 32.41 per share, with provisions for adjustments based on various corporate actions [4][5]. Group 3: Use of Proceeds - The total planned investment for the projects funded by the bond proceeds is RMB 74.32 million, with the company committing to cover any shortfall if the actual net proceeds are less than this amount [11]. - The company will utilize its own funds or other means to initiate project investments before the bond proceeds are available [11]. Group 4: Credit Rating - The bonds have been rated "AA-" by China Chengxin International Credit Rating Co., Ltd., with a stable outlook [11][12]. Group 5: Redemption and Conversion Rights - The company has decided not to exercise its right to redeem the bonds early, despite meeting the conditions for redemption, to protect investor interests [17]. - Holders of the convertible bonds have the right to convert their bonds into shares during the specified conversion period from June 2, 2023, to November 27, 2028 [14].

盛剑科技(603324.SH)公告，此前于2025年8月8日，公司和保荐人国泰海通证券股份有限公司向上交所 提交了《上海盛剑科技股份有限公司关于撤回上海盛剑科技股份有限公司向不特定对象发行可转换公司 债券申请文件的申请》和《国泰海通证券股份有限公司关于撤销对上海盛剑科技股份有限公司向不特定 对象发行可转换公司债券保荐的申请》，分别申请撤回公司向不特定对象发行可转换公司债券的申请文 件和申请撤销对公司向不特定对象发行可转换公司债券的保荐工作。 2025年8月11日，公司收到上交所《关于终止对上海盛剑科技股份有限公司向不特定对象发行可转换公 司债券审核的决定》，上交所决定终止对公司向不特定对象发行可转换公司债券的审核。 ...

Group 1 - The company held its 24th meeting of the 4th Supervisory Board on August 12, 2025, with all three supervisors present [1] - The Supervisory Board approved the proposal for issuing convertible bonds to unspecified objects, with a total fundraising amount of RMB 308.447 million, issuing 308,447 lots (3,084,470 bonds) [2][8] - The convertible bonds will have a face value of RMB 100.00 each and a term of 6 years, from August 15, 2025, to August 14, 2031 [2][3] Group 2 - The annual interest rates for the convertible bonds are set at 0.20% for the first year, increasing to 1.80% by the sixth year, with interest paid annually [2][3] - The initial conversion price for the bonds is set at RMB 12.70 per share, based on the average trading price of the company's A shares [5] - The company will redeem any unconverted bonds at 110% of the face value plus the last interest payment within 5 trading days after maturity [5][6] Group 3 - The company will establish a special account for the funds raised from the convertible bond issuance and sign a fund supervision agreement [8][9] - The company plans to cancel the Supervisory Board and amend its Articles of Association accordingly, transferring the supervisory responsibilities to the Audit Committee of the Board [9][10] - The proposal to cancel the Supervisory Board requires approval from the company's shareholders' meeting to take effect [9]

| | | 浙江美力科技股份有限公司 | 2025 年半年 | | --- | --- | --- | --- | | 度报告摘要 | | | | | 证券代码：300611 证券简称：美力科技 | | | 公告编号： | | 2025-038 | | | | | 浙江美力科技股份有限公司 2025 年半年度报告摘要 | | | | | 一、重要提示 | | | | | 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 | | | | | 资者应当到证监 | | | | | 会指定媒体仔细阅读半年度报告全文。 | | | | | 所有董事均已出席了审议本报告的董事会会议。 | | | | | 非标准审计意见提示 | | | | | □适用 ?不适用 | | | | | 董事会审议的报告期利润分配预案或公积金转增股本预案 | | | | | □适用 ?不适用 | | | | | 公司计划不派发现金红利，不送红股，不以公积金转增股本。 | | | | | 董事会决议通过的本报告期优先股利润分配预案 | | | | | □适用 ?不适用 | | | | | 二、公司基本情况 ...

Summary of Key Points Core Viewpoint - The announcement details the share reduction plan by the controlling shareholder and actual controller of Tonglian Precision, indicating a planned reduction of up to 3,805,730 shares, which represents a maximum of 2.3750% of the company's total share capital [1][2]. Share Reduction Details - The controlling shareholder, Yang Hu, plans to reduce his holdings by up to 3,805,730 shares, with a breakdown of 3,204,826 shares through block trading (up to 2.0000% of total shares) and 600,904 shares through centralized bidding (up to 0.3750% of total shares) [1][2]. - Shenzhen Panhai Tonglian Technology Enterprise (Limited Partnership) intends to reduce its holdings by up to 1,001,508 shares, accounting for up to 0.6250% of the total share capital [1][2]. Reduction Method and Timeline - The reduction will occur through block trading and centralized bidding over a period of three months starting from 15 trading days after the announcement [2]. - The total number of shares reduced by Yang Hu and Panhai Tonglian combined will not exceed 1.00% of the total share capital in any consecutive 90-day period for centralized bidding and 2.00% for block trading [2]. Current Shareholding Structure - As of the announcement date, Yang Hu holds 34,909,595 shares (21.79% of total shares), while Panhai Tonglian holds 8,557,711 shares (5.34% of total shares) [2][3]. Impact on Company Control - The share reduction will not lead to a change in the controlling shareholder or actual controller and is not expected to significantly impact the company's ongoing operations [4]. Convertible Bond Issuance - Tonglian Precision plans to issue convertible bonds with a total amount not exceeding 595 million yuan, intended for a new smart terminal component manufacturing project, working capital, and bank loan repayment [5][6]. - The convertible bonds will be issued at par value, with a maturity of six years, and the initial conversion price will be based on the average trading price of the company's shares prior to the announcement [4][5]. Fund Allocation - The total investment for the smart terminal component project is approximately 490.83 million yuan, with 465 million yuan allocated from the bond issuance [6]. - The company aims to prioritize existing shareholders for the bond issuance, which will not be secured [5][6]. Historical Context - Tonglian Precision was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 27, 2021, raising 855 million yuan, with a public offering price of 42.76 yuan per share [7][8].

中国经济网北京8月11日讯 富临精工(300432.SZ)近日发布关于实际控制人减持股份实施情况的公告。公司于 近日收到实际控制人安治富出具的《关于股份减持计划实施完毕的告知函》，截止公告披露日，安治富本次减 持计划已经全部实施完毕。 富临精工公告显示，2025年8月4日至2025年8月8日，安治富通过集中竞价交易减持17,097,400股，减持均价 13.05元/股。经计算，安治富减持金额2.23亿元。 | | 集中竞价交易 | | 13.05 | 17.097.400 | | | --- | --- | --- | --- | --- | --- | | | | -2025 年8月8日 | | | | | 股东名称 安治富 | 减持方式 | 减持期间 2025年8月4日 合计 | 减持均价(元/股) | 减持股数(股) 17,097,400 | 减持比例(%) 1.00 1.00 | | 股份性质 | | 本次变动前持有股份 | | 本次变动后持有股份 | | --- | --- | --- | --- | --- | | | 股数(股) | 占总股本比例(%) | 股数(股) | 占总股本比例(%) | ...

Group 1 - The core opinion of the article is that Minsheng Securities has conducted a review regarding Zhejiang Titan Co., Ltd.'s decision not to redeem the "Titan Convertible Bonds" in advance, ensuring compliance with relevant regulations and protecting investor interests [1][7][8] - The "Titan Convertible Bonds" were issued with a total amount of 295.5 million yuan and have a term of 6 years, starting from November 15, 2023 [1][2] - The initial conversion price of the "Titan Convertible Bonds" was set at 13.81 yuan per share, which has been adjusted to 13.27 yuan per share due to corporate actions [2][3] Group 2 - The conditional redemption clause allows the company to redeem the bonds if the closing price exceeds 130% of the conversion price for at least 15 trading days [4][6] - The redemption condition was triggered as the stock price was above 17.25 yuan per share for the required period [6][7] - The company’s board decided not to exercise the redemption right for the next six months to protect investor interests, with a review planned after February 8, 2026 [7][8] Group 3 - There were no transactions involving the "Titan Convertible Bonds" by major shareholders or executives in the six months leading up to the redemption condition [8] - The review by the sponsor institution confirmed that the decision not to redeem the bonds was approved by the company's board and complied with all relevant regulations [8]

Group 1 - The third meeting of the supervisory board of Shanghai Shengjian Technology Co., Ltd. was held on August 8, 2025, with all three supervisors present [1][2] - The supervisory board approved the proposal to terminate the issuance of convertible bonds to unspecified objects and withdraw the application documents, stating that this decision would not have a significant adverse impact on the company's operations [1][2] - The voting result for the proposal was unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The meeting was conducted in accordance with relevant laws, regulations, and the company's articles of association [1] - The announcement regarding the termination of the bond issuance is available on the Shanghai Stock Exchange website [2]